127 related articles for article (PubMed ID: 33443961)
1. Patient-specific Extravasation Dosimetry Using Uptake Probe Measurements.
Osborne D; Kiser JW; Knowland J; Townsend D; Fisher DR
Health Phys; 2021 Mar; 120(3):339-343. PubMed ID: 33443961
[TBL] [Abstract][Full Text] [Related]
2. Dose Estimation for Extravasation of 177Lu, 99mTc, and 18F.
Tsorxe IY; Hayes RB
Health Phys; 2023 Mar; 124(3):217-220. PubMed ID: 36719937
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric consequences of radiopharmaceutical infiltrations.
Castronovo FP; McKusick KA; Strauss HW
Invest Radiol; 1994 Jan; 29(1):59-64. PubMed ID: 8144339
[TBL] [Abstract][Full Text] [Related]
4. The Scientific and Clinical Case for Reviewing Diagnostic Radiopharmaceutical Extravasation Long-Standing Assumptions.
Osborne D; Lattanze R; Knowland J; Bryant TE; Barvi I; Fu Y; Kiser JW
Front Med (Lausanne); 2021; 8():684157. PubMed ID: 34262915
[No Abstract] [Full Text] [Related]
5. Practical Tools for Patient-specific Characterization and Dosimetry of Radiopharmaceutical Extravasation.
Wilson S; Osborne D; Long M; Knowland J; Fisher DR
Health Phys; 2022 Nov; 123(5):343-347. PubMed ID: 35838538
[TBL] [Abstract][Full Text] [Related]
6. Primary radiation dosimetry of a novel PET radiopharmaceutical
Cheki M; Gali H
Hell J Nucl Med; 2017; 20(3):241-246. PubMed ID: 29177263
[TBL] [Abstract][Full Text] [Related]
7. Estimation of absorbed radiation doses to skin and S-values for organs at risk due to nasal administration of PET agents using Monte Carlo simulations.
O'Doherty J; Mangini CD; Hamby DM; Boozer D; Singh N; Hippeläinen E
Med Phys; 2021 Feb; 48(2):871-880. PubMed ID: 33330987
[TBL] [Abstract][Full Text] [Related]
8. Radiopharmaceutical Extravasation: Pragmatic Radiation Protection.
Fisher DR; Liverett M
Health Phys; 2022 Apr; 122(4):537-539. PubMed ID: 35085120
[TBL] [Abstract][Full Text] [Related]
9. Correction for FDG PET dose extravasations: Monte Carlo validation and quantitative evaluation of patient studies.
Silva-Rodríguez J; Aguiar P; Sánchez M; Mosquera J; Luna-Vega V; Cortés J; Garrido M; Pombar M; Ruibal A
Med Phys; 2014 May; 41(5):052502. PubMed ID: 24784399
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional personalized Monte Carlo dosimetry in 90Y resin microspheres therapy of hepatic metastases: nontumoral liver and lungs radiation protection considerations and treatment planning optimization.
Petitguillaume A; Bernardini M; Hadid L; de Labriolle-Vaylet C; Franck D; Desbrée A
J Nucl Med; 2014 Mar; 55(3):405-13. PubMed ID: 24504053
[TBL] [Abstract][Full Text] [Related]
11. Patient-adapted organ absorbed dose and effective dose estimates in pediatric 18F-FDG positron emission tomography/computed tomography studies.
Quinn BM; Gao Y; Mahmood U; Pandit-Taskar N; Behr G; Zanzonico P; Dauer LT
BMC Med Imaging; 2020 Jan; 20(1):9. PubMed ID: 31996149
[TBL] [Abstract][Full Text] [Related]
12. The infiltrated radiopharmaceutical injection: dosimetric considerations.
Castronovo FP; McKusick KA; Strauss HW
Eur J Nucl Med; 1988; 14(2):93-7. PubMed ID: 3164675
[TBL] [Abstract][Full Text] [Related]
13. Considerations for applying VARSKIN mod 2 to skin dose calculations averaged over 10 cm2.
Durham JS
Health Phys; 2004 Feb; 86(2 Suppl):S11-4. PubMed ID: 14744063
[TBL] [Abstract][Full Text] [Related]
14. Topical Sensor for the Assessment of Injection Quality for 18F-FDG, 68Ga-PSMA and 68Ga-DOTATATE Positron Emission Tomography.
Sanchez S; Currie GM
J Med Imaging Radiat Sci; 2020 Jun; 51(2):247-255. PubMed ID: 32089515
[TBL] [Abstract][Full Text] [Related]
15. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.
Elgqvist J; Bernhardt P; Hultborn R; Jensen H; Karlsson B; Lindegren S; Warnhammar E; Jacobsson L
J Nucl Med; 2005 Mar; 46(3):464-71. PubMed ID: 15750160
[TBL] [Abstract][Full Text] [Related]
16. Internal radiation dose assessment of radiopharmaceuticals prepared with cyclotron-produced
Meléndez-Alafort L; Ferro-Flores G; De Nardo L; Bello M; Paiusco M; Negri A; Zorz A; Uzunov N; Esposito J; Rosato A
Med Phys; 2019 Mar; 46(3):1437-1446. PubMed ID: 30661241
[TBL] [Abstract][Full Text] [Related]
17. Experimental validation of Monte Carlo dosimetry for therapeutic beta emitters with radiochromic film in a 3D-printed phantom.
Van B; Dewaraja YK; Niedbala JT; Rosebush G; Kazmierski M; Hubers D; Mikell JK; Wilderman SJ
Med Phys; 2023 Jan; 50(1):540-556. PubMed ID: 35983857
[TBL] [Abstract][Full Text] [Related]
18. IDACstar: A MCNP Application to Perform Realistic Dose Estimations from Internal or External Contamination of Radiopharmaceuticals.
Ören Ü; Hiller M; Andersson M
Radiat Prot Dosimetry; 2017 Apr; 174(3):406-411. PubMed ID: 27475750
[TBL] [Abstract][Full Text] [Related]
19. Technical note: A wearable radiation measurement system for collection of patient-specific time-activity data in radiopharmaceutical therapy: system design and Monte Carlo simulation results.
Morganti S; Collamati F; Faccini R; Iaccarino G; Mancini-Terracciano C; Mirabelli R; Nicolanti F; Pacilio M; Soriani A; Solfaroli-Camillocci E
Med Phys; 2021 Dec; 48(12):8117-8126. PubMed ID: 34704618
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional Monte Carlo-based voxel-wise tumor dosimetry in patients with neuroendocrine tumors who underwent
Goetz TI; Lang EW; Prante O; Maier A; Cordes M; Kuwert T; Ritt P; Schmidkonz C
Ann Nucl Med; 2020 Apr; 34(4):244-253. PubMed ID: 32114682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
